These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 24157876)

  • 41. Frequent inactivation of RAMP2, EFEMP1 and Dutt1 in lung cancer by promoter hypermethylation.
    Yue W; Dacic S; Sun Q; Landreneau R; Guo M; Zhou W; Siegfried JM; Yu J; Zhang L
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4336-44. PubMed ID: 17671114
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of GPX3 epigenetically silenced by CpG methylation in human esophageal squamous cell carcinoma.
    He Y; Wang Y; Li P; Zhu S; Wang J; Zhang S
    Dig Dis Sci; 2011 Mar; 56(3):681-8. PubMed ID: 20725785
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Zinc-finger protein 331, a novel putative tumor suppressor, suppresses growth and invasiveness of gastric cancer.
    Yu J; Liang QY; Wang J; Cheng Y; Wang S; Poon TC; Go MY; Tao Q; Chang Z; Sung JJ
    Oncogene; 2013 Jan; 32(3):307-17. PubMed ID: 22370639
    [TBL] [Abstract][Full Text] [Related]  

  • 44. SMG1 acts as a novel potential tumor suppressor with epigenetic inactivation in acute myeloid leukemia.
    Du Y; Lu F; Li P; Ye J; Ji M; Ma D; Ji C
    Int J Mol Sci; 2014 Sep; 15(9):17065-76. PubMed ID: 25257528
    [TBL] [Abstract][Full Text] [Related]  

  • 45. NGX6 gene mediated by promoter methylation as a potential molecular marker in colorectal cancer.
    Liu M; Peng Y; Wang X; Guo Q; Shen S; Li G
    BMC Cancer; 2010 Apr; 10():160. PubMed ID: 20423473
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epigenetic Suppression of the T-box Subfamily 2 (
    Nehme E; Rahal Z; Sinjab A; Khalil A; Chami H; Nemer G; Kadara H
    Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30866410
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hypermethylated CD36 gene affected the progression of lung cancer.
    Sun Q; Zhang W; Wang L; Guo F; Song D; Zhang Q; Zhang D; Fan Y; Wang J
    Gene; 2018 Dec; 678():395-406. PubMed ID: 29969695
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Epigenetic inactivation of HOXD10 is associated with human colon cancer via inhibiting the RHOC/AKT/MAPK signaling pathway.
    Yuan YH; Wang HY; Lai Y; Zhong W; Liang WL; Yan FD; Yu Z; Chen JK; Lin Y
    Cell Commun Signal; 2019 Jan; 17(1):9. PubMed ID: 30683109
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tumor suppressor LHX6 upregulation contributes to the inhibitory effect of miR-346 knockdown on colorectal cancer cell growth.
    Li X; Zhou Y; Wen P; Yuan Y; Xiao Z; Shi H; Zhou H
    Environ Toxicol; 2022 Mar; 37(3):435-445. PubMed ID: 34773443
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Methylation decreases the Bin1 tumor suppressor in ESCC and restoration by decitabine inhibits the epithelial mesenchymal transition.
    Wang X; Wang J; Jia Y; Wang Y; Han X; Duan Y; Lv W; Ma M; Liu L
    Oncotarget; 2017 Mar; 8(12):19661-19673. PubMed ID: 28152502
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Epigenetic inactivation of EFEMP1 is associated with tumor suppressive function in endometrial carcinoma.
    Yang T; Qiu H; Bao W; Li B; Lu C; Du G; Luo X; Wang L; Wan X
    PLoS One; 2013; 8(6):e67458. PubMed ID: 23840707
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epigenetic silencing of CHD5, a novel tumor-suppressor gene, occurs in early colorectal cancer stages.
    Fatemi M; Paul TA; Brodeur GM; Shokrani B; Brim H; Ashktorab H
    Cancer; 2014 Jan; 120(2):172-80. PubMed ID: 24243398
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hypermethylation and silencing of the putative tumor suppressor Tazarotene-induced gene 1 in human cancers.
    Youssef EM; Chen XQ; Higuchi E; Kondo Y; Garcia-Manero G; Lotan R; Issa JP
    Cancer Res; 2004 Apr; 64(7):2411-7. PubMed ID: 15059893
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Promoter hypermethylation of KLF4 inactivates its tumor suppressor function in cervical carcinogenesis.
    Yang WT; Zheng PS
    PLoS One; 2014; 9(2):e88827. PubMed ID: 24551169
    [TBL] [Abstract][Full Text] [Related]  

  • 55. PAX3 is a novel tumor suppressor by regulating the activities of major signaling pathways and transcription factor FOXO3a in thyroid cancer.
    Liu W; Sui F; Liu J; Wang M; Tian S; Ji M; Shi B; Hou P
    Oncotarget; 2016 Aug; 7(34):54744-54757. PubMed ID: 27458157
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lhx6 and Lhx8: cell fate regulators and beyond.
    Zhou C; Yang G; Chen M; He L; Xiang L; Ricupero C; Mao JJ; Ling J
    FASEB J; 2015 Oct; 29(10):4083-91. PubMed ID: 26148970
    [TBL] [Abstract][Full Text] [Related]  

  • 57. HORMAD2 methylation-mediated epigenetic regulation of gene expression in thyroid cancer.
    Lin Q; Hou S; Guan F; Lin C
    J Cell Mol Med; 2018 Oct; 22(10):4640-4652. PubMed ID: 30039914
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Putative tumour-suppressor gene DAB2 is frequently down regulated by promoter hypermethylation in nasopharyngeal carcinoma.
    Tong JH; Ng DC; Chau SL; So KK; Leung PP; Lee TL; Lung RW; Chan MW; Chan AW; Lo KW; To KF
    BMC Cancer; 2010 Jun; 10():253. PubMed ID: 20525238
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CHD5, a tumor suppressor that is epigenetically silenced in lung cancer.
    Zhao R; Yan Q; Lv J; Huang H; Zheng W; Zhang B; Ma W
    Lung Cancer; 2012 Jun; 76(3):324-31. PubMed ID: 22186629
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The relationship between the TSLC1 silencing and DNA methylation in human lung cancer cells].
    Ming S; Gao J; Sun T
    Zhongguo Fei Ai Za Zhi; 2010 May; 13(5):464-9. PubMed ID: 20677643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.